Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy-Reference-Cited by-同舟云学术

Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy

Published:2021-12 Issue:25 Volume:78 Page:2518-2532
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Hegde Sheila M.,Lester Steven J.,Solomon Scott D.,Michels Michelle,Elliott Perry M.,Nagueh Sherif F.,Choudhury Lubna,Zemanek David,Zwas Donna R.,Jacoby Daniel,Wang Andrew,Ho Carolyn Y.,Li Wanying,Sehnert Amy J.,Olivotto Iacopo,Abraham Theodore P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy;Marian;Circ Res,2017

2. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Ommen;J Am Coll Cardiol,2020

3. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy;Maron;N Engl J Med,2003

4. Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe);Ho;Circulation,2018

5. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC);Elliott;Eur Heart J,2014

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Drug Therapy Efficacy in Patients With Hypertrophic Cardiomyopathy: A Network Meta-Analysis;The American Journal of Cardiology;2024-09

2. Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy;Journal of the American College of Cardiology;2024-09

3. Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM;JACC: Cardiovascular Imaging;2024-09

4. Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy;The EMBO Journal;2024-08-27

5. Accelerated hypertension following mavacamten introduction in severe obstructive hypertrophic cardiomyopathy with hypertension: a case report;European Heart Journal - Case Reports;2024-08-26